Leadership Overview
AbbVie has 10 executives leading key functions including strategy, operations, finance, and research.
Driven by a commitment to patient well-being, AbbVie focuses on developing innovative medicines to address complex global health challenges, enhancing quality of life through scientific advancement.
Driven by a commitment to patient well-being, AbbVie focuses on developing innovative medicines to address complex global health challenges, enhancing quality of life through scientific advancement.
Leadership Roles at AbbVie
Itamar Seindlis - Director, Finance & Chief Financial Officer
Itamar Seindlis, the Director, Finance & Chief Financial Officer at AbbVie, directs the companys financial strategy and operations, ensuring robust fiscal management and resource allocation. Seindlis oversees all financial planning, reporting, and investment activities, supporting AbbVies commitment to developing innovative medicines and health solutions. This critical role involves guiding financial decisions that enable sustained growth and investment in research and development, particularly in areas with significant unmet medical needs. Itamar Seindlis's financial acumen is essential for maintaining the companys financial health and supporting its long-term strategic objectives. The CFO's leadership ensures that financial resources are effectively deployed to maximize patient impact and shareholder value.
Eduardo Goya - Director, Finance (Country & Chief Financial Officer
Eduardo Goya, the Director, Finance (Country & Chief Financial Officer at AbbVie, manages the financial operations and strategic planning for specific country markets, ensuring fiscal responsibility and growth. Goya oversees budgeting, financial reporting, and resource allocation within designated regions, supporting AbbVies global mission to deliver innovative health solutions. This executive role involves navigating local market financial complexities and aligning regional financial strategies with overarching corporate objectives. Eduardo Goya's financial leadership is essential for optimizing performance and ensuring sustainable operations in diverse international settings. The CFO's commitment to financial integrity supports AbbVies ability to invest in critical research and development initiatives worldwide.
Natanel Reshef - Chief Operating Officer
Natanel Reshef, the Chief Operating Officer at AbbVie, orchestrates the companys global operational infrastructure, ensuring efficient and effective delivery of its biopharmaceutical products and services. Reshef drives operational excellence across manufacturing, supply chain, and commercial operations, directly supporting AbbVies commitment to addressing complex medical challenges. This executive role involves optimizing resource allocation and implementing best practices to enhance productivity and reduce costs, thereby enabling greater investment in research and development. Natanel Reshef's leadership ensures that the companys therapeutic advancements reach patients worldwide with reliability and speed. The COO's strategic vision guides the operational teams in scaling operations to meet growing global demand for innovative health solutions, reinforcing AbbVies market position.
Portia Chen - Chief of Staff
Portia Chen, the Chief of Staff at AbbVie, directs strategic initiatives and operational alignment across key departments. This leadership role ensures seamless execution of corporate objectives, particularly in fostering cross-functional collaboration to advance AbbVie's mission of developing innovative medicines. Chen's oversight extends to optimizing internal processes and facilitating communication between executive leadership and various operational teams. The focus remains on enhancing efficiency and driving progress in areas critical to the company's growth and patient impact. By managing critical projects and supporting executive decision-making, Portia Chen directly contributes to the company's ability to tackle complex medical challenges and improve patient outcomes globally. This position requires a deep understanding of the biopharmaceutical landscape and a commitment to operational excellence.
Valerie Menaker - Director, Strategic Operations & Oncology Early Development Operations Chief of Staff
Valerie Menaker, the Director, Strategic Operations & Oncology Early Development Operations Chief of Staff at AbbVie, spearheads critical operational strategies within oncology research and development. Menaker ensures the efficient progression of early-stage oncology programs, aligning strategic objectives with operational execution to accelerate the delivery of potentially life-altering therapies. This role involves close collaboration with R&D teams and executive leadership to streamline processes, manage resources effectively, and mitigate risks in the complex drug development lifecycle. Valerie Menaker's focus on operational excellence within oncology early development directly supports AbbVies mission to address significant unmet medical needs in cancer treatment. The strategic oversight provided by Menaker is vital for advancing the pipeline and ensuring timely progress towards clinical trials and regulatory submissions.
Jenina Nunez - Chief of Staff, Intercontinental
Jenina Nunez, the Chief of Staff, Intercontinental at AbbVie, directs strategic operations and ensures cohesive execution of company initiatives across diverse international markets. Nunez facilitates communication and collaboration among regional leadership teams, driving alignment with global corporate strategies to enhance patient access to innovative medicines. This position involves navigating complex regulatory environments and market dynamics across the Intercontinental region, optimizing operational efficiency to support AbbVies growth objectives. Jenina Nunez's leadership ensures that regional operations effectively contribute to the companys overarching mission of addressing global health challenges. By fostering strong relationships and implementing best practices, Nunez strengthens AbbVies presence and impact in key international territories.
Martin Hayes - Global Neuroscience & Ophthalmology Research Chief of Staff
Martin Hayes, the Global Neuroscience & Ophthalmology Research Chief of Staff at AbbVie, drives strategic operational alignment within critical research areas. Hayes ensures that global neuroscience and ophthalmology research initiatives progress efficiently, supporting the development of novel therapies for complex neurological and eye conditions. This role involves coordinating cross-functional teams, managing research budgets, and facilitating communication between research scientists and executive leadership to accelerate discovery and development timelines. Martin Hayes's operational expertise is crucial for advancing AbbVies pipeline in these specialized therapeutic areas, directly contributing to the companys commitment to improving patient outcomes. The strategic oversight ensures resources are optimally allocated to address significant unmet medical needs.
Sarah Kopecky-Bromberg - Strategic Planning Director, Development & Operations, Specialty Chief of Staff
Sarah Kopecky-Bromberg, the Strategic Planning Director, Development & Operations, Specialty Chief of Staff at AbbVie, leads strategic planning and operational execution for specialty therapeutic areas. Kopecky-Bromberg ensures that development and operations teams are aligned with corporate goals, driving efficiency and innovation in bringing specialty medicines to patients. This executive function involves meticulous planning, resource management, and cross-departmental coordination to overcome development hurdles and accelerate market entry. Sarah Kopecky-Bromberg's strategic insights are vital for navigating the complexities of specialty drug development, reinforcing AbbVies dedication to addressing serious and life-altering diseases. The focus remains on optimizing the entire development and operational lifecycle for specialty products.
Donald Wyma - Chief of Staff, Oncology Discovery
Donald Wyma, the Chief of Staff, Oncology Discovery at AbbVie, drives strategic alignment and operational efficiency within the companys oncology research initiatives. Wyma ensures that discovery teams have the resources and support needed to accelerate the development of novel cancer therapies, directly contributing to AbbVies mission of addressing complex medical challenges. This leadership position involves coordinating critical research projects, managing operational workflows, and facilitating communication between discovery scientists and executive leadership. Donald Wyma's focus on optimizing the oncology discovery process is vital for advancing AbbVies pipeline and bringing innovative treatments to patients facing cancer. The operational strategies implemented by Wyma enhance the speed and effectiveness of groundbreaking research.
Mark Schacher - Director, Data and Statistical Science and Chief of Staff
Mark Schacher, the Director, Data and Statistical Science and Chief of Staff at AbbVie, leads the strategic application of data analytics and statistical science across the organization. Schacher ensures that data-driven insights inform critical decision-making, enhancing the efficiency and effectiveness of drug discovery, development, and commercialization efforts. This role involves overseeing the integration of advanced analytical methodologies and supporting operational teams in leveraging data for optimal outcomes. Mark Schacher's expertise is crucial for advancing AbbVies commitment to innovation and patient well-being by unlocking the full potential of scientific data. The strategic direction provided by Schacher supports the development of targeted therapies and improves patient care.
Explore Leadership Teams in Manufacturing
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions.
Company Leadership AG
SS
KW
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership MR
BG
BK
JS
Founded in 1947 and headquartered in Mumbai, Indoco Remedies Limited is a fully integrated, research-oriented pharma company. Indoco specializes in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Company Leadership BD
PG
PA
IFF Pharma Solutions develops high-quality pharmaceutical excipients and biopolymers that support advanced drug delivery and biomedical applications. The company focuses on providing reliable, performance-driven ingredients that help pharmaceutical manufacturers improve formulation efficiency, product stability, and patient outcomes. With strong expertise in quality, regulatory compliance, and innovation, IFF Pharma Solutions plays a key role in enabling safe and effective medicines worldwide.
Company Leadership CP
Frequently Asked Questions Regarding AbbVie Top Executives and Leadership Team
Unlock more people and company data
